Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Pulmonary Hypertension, June 2026 Free Subscription Abstracts Retrieve all available abstracts of the following 133 articles: HTML format

Single Articles

1. ZHENG K, Zheng X, Li J, Xu M, et al
   Single-cell transcriptomics reveals NDRG1/TGF?beta1 associated vascular smooth muscle cell phenotypic switching in chronic thromboembolic pulmonary hypertension.
   J Thromb Thrombolysis. 2026 May 29. doi: 10.1007/s11239-026-03288.
   PubMed    
   Abstract available
   
   

2. MCCARTHY BE, Feng R, Bernardo R, Shlobin OA, et al
   Insurance and Treatment Patterns in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry.
   Ann Am Thorac Soc. 2026 May 29:aaoag141. doi: 10.1093.
   PubMed    
   Abstract available
   
   

3. SCABELLO RT, de Carvalho-Pinto RM, de Parodi LN, de Almeida G, et al
   Prevalence, pathogenesis, and clinical impact of pulmonary hypertension associated with chronic obstructive pulmonary disease.
   Front Cardiovasc Med. 2026;13:1700063.
   PubMed    
   Abstract available
   
   

4. ANDROSHCHUK V, Long E, Sillett C, Chehab O, et al
   Multi-chamber three-dimensional myocardial strain assessment by computed tomography: a comparison with speckle tracking echocardiography and association with pulmonary hypertension in severe aortic stenosis.
   Front Cardiovasc Med. 2026;13:1774091.
   PubMed    
   Abstract available
   
   

5. KRASIC S, Hermuzi A, Dizdarevic I, Topic V, et al
   Case Report: Post-Total anomalous pulmonary venous connection pulmonary hypertension - novel treatment using sirolimus and atrial flow regulator implantation.
   Front Cardiovasc Med. 2026;13:1783773.
   PubMed    
   Abstract available
   
   

6. TARRAS ES, Arun AS, Joseph P, Heerdt PM, et al
   Right Ventricular End-Ejection Pressure Predicts Mortality in Patients With Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction.
   Compr Physiol. 2026;16:e70187.
   PubMed    
   Abstract available
   
   

7. CHEN M, Liao X, Li F, Liu J, et al
   The MCP-1/CCR2-CD16(+) monocyte axis drives thrombus fibrosis in Chronic Thromboembolic Pulmonary Hypertension.
   J Transl Med. 2026 May 28. doi: 10.1186/s12967-026-08283.
   PubMed    
   Abstract available
   
   

8. LUNA-LOPEZ R, Garcia-Alvarez A
   Growing with the patient: toward a lifespan risk score for pediatric pulmonary hypertension.
   Rev Esp Cardiol (Engl Ed). 2026 May 27:S1885-5857(26)00107.
   PubMed    
   
   
   

9. KHURANA JK, Lipsitz S, Geisser DL, Moynihan KM, et al
   Child Opportunity Index Influences Pediatric Pulmonary Hypertension Outcomes: Analyses From the Pediatric Health Information System.
   JACC Adv. 2026;5:102773.
   PubMed    
   Abstract available
   
   

10. YUAN H, Chen B, Gao D, Zhang L, et al
    I-tRF-Asp Promotes Vascular Remodeling in Hypoxic Pulmonary Hypertension Via hnRNPU Phase Separation, Which Affects TCF7L2 Alternative Splicing.
    Arterioscler Thromb Vasc Biol. 2026 May 28. doi: 10.1161/ATVBAHA.126.324681.
    PubMed    
    Abstract available
    
    

11. HE P, Tan W, Zhu Y, Fan J, et al
    Ginsenoside Rg1 attenuates right ventricular remodeling in hypoxic pulmonary hypertension and is associated with suppression of HIF-1alpha-related glycolytic signaling.
    J Basic Clin Physiol Pharmacol. 2026 May 28. doi: 10.1515/jbcpp-2026-0090.
    PubMed    
    Abstract available
    
    

12. ERAKY AM, Mokhtar Y, Grabau G, Khan A, et al
    Calcium Channel Blockers in Critical Care Medicine: Current Clinical Applications and Future Investigational Perspectives.
    Med Sci (Basel). 2026;14:213.
    PubMed    
    Abstract available
    
    

13. ZHOU Q, Zhu G, Zhang P, Qi B, et al
    Construction and Validation of a Predictive Model for Chronic Obstructive Pulmonary Disease with Pulmonary Hypertension Based on Lasso Regression.
    Int J Gen Med. 2026;19:599529.
    PubMed    
    Abstract available
    
    

14. ISHII T, Anzai T, Uchida K, Hosokawa S, et al
    Registry-based estimation of cardiac event-free survival in congenital heart disease complicated by pulmonary hypertension: A nationwide registry study from Japan.
    Int J Cardiol Congenit Heart Dis. 2026;25:100679.
    PubMed    
    Abstract available
    
    

15. AMIRI U, Keceli E, Andersen MO, Mojaddedi S, et al
    Advanced right ventricular evaluation in pulmonary hypertension: the role of 3D echocardiography and strain analysis.
    Eur Heart J Imaging Methods Pract. 2026;4:qyag067.
    PubMed    
    Abstract available
    
    

16. GHANI H, Thillai M, Walsh S, Bussell E, et al
    Anthropometry, sex, and age at diagnosis affect pulmonary blood volume quantification from computed tomography pulmonary angiography in pulmonary hypertension assessment.
    Front Cardiovasc Med. 2026;13:1815977.
    PubMed    
    Abstract available
    
    

17. CHADDA KR, Sathivelu S, Armstrong SK, Edling C, et al
    Rare Models: Use of a Novel Translational Model for Diffuse Alveolar Haemorrhage.
    Int J Mol Sci. 2026;27:4157.
    PubMed    
    Abstract available
    
    

18. CONDE-CAMACHO R, Tuta-Quintero E, Mora-Barrero A, Bastidas-Goyes A, et al
    Hemodynamic and Thrombotic Vulnerability in Pulmonary Arterial Hypertension at High Altitude: Multivariable Predictors of Mortality.
    Medicina (Kaunas). 2026;62:996.
    PubMed    
    Abstract available
    
    

19. SUN Y, Zhang Q, Huang Y, Liu X, et al
    A Rare Case of Multi-System Involvement and Hereditary Pulmonary Hypertension Caused by De Novo Heterozygous CAV1 Mutation in a Pediatric Patient.
    Children (Basel). 2026;13:694.
    PubMed    
    Abstract available
    
    

20. VYAS-READ S, Bhombal S, Siddaiah R, Cua CL, et al
    Echocardiographic Detection of Pulmonary Hypertension and Right Ventricular Failure in Infants with Bronchopulmonary Dysplasia: A Survey of the BPD Collaborative.
    Children (Basel). 2026;13:646.
    PubMed    
    Abstract available
    
    

21. SILVA VBC, Lucina SB, Wolf M, Sarraff AP, et al
    Right ventricular systolic function in dogs with pulmonary hypertension can be assessed using tissue motion annular displacement.
    Am J Vet Res. 2026 May 26:1-8. doi: 10.2460/ajvr.26.03.0107.
    PubMed    
    Abstract available
    
    

22. CHEN Z, Pang L, Zheng Y, Xu L, et al
    Multi-Omics Identification of Biomarkers for High-Altitude Pulmonary Hypertension.
    J Cardiovasc Dev Dis. 2026;13:195.
    PubMed    
    Abstract available
    
    

23. RAMAZANI N, Barnes L, Wong A, Sharma D, et al
    The New Era of Pulmonary Hypertension: The Dawn of Disease Modification & Therapeutic Modalities.
    J Cardiovasc Dev Dis. 2026;13:174.
    PubMed    
    Abstract available
    
    

24. LIU Z, Liu X, Mprah R, Sun H, et al
    Sodium Selenite Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension by Upregulating GPX3 and Ameliorating Vascular Remodeling.
    Physiol Res. 2026;75:325-335.
    PubMed    
    Abstract available
    
    

25. WANG D, Li Y, Wang H, Zhang J, et al
    Shortened Pulmonary Pulse Wave Transit Time in High-Altitude Residents Without Pulmonary Hypertension: An Doppler Echocardiography Study.
    Physiol Res. 2026;75:315-323.
    PubMed    
    Abstract available
    
    

26. WANG D, Fang Y, Wu X, Zhang J, et al
    Increased Right Ventricular Cardiac Output to Left Ventricular Cardiac Output Ratio in High-Altitude Residents Without Pulmonary Hypertension: An Echocardiography Study.
    Physiol Res. 2026;75:257-264.
    PubMed    
    Abstract available
    
    

27. TRINDADE P, Dias A, Santos FP, Froes F, et al
    Management of acute respiratory failure in pulmonary hypertension in the ICU: Ten years of experience.
    Pulmonology. 2026;32:2679340.
    PubMed    
    
    
    

28. TERAMACHI R, Fukihara J, Ichihara S, Kataoka K, et al
    Early risk response to vasodilators and outcomes in interstitial lung disease associated pulmonary hypertension.
    Respir Investig. 2026;64:101453.
    PubMed    
    Abstract available
    
    

29. BULARD BA, Kumpfbeck AR, Woo Y, Simonds E, et al
    Structured Exercise Regimen in Pulmonary Hypertension-Right Ventricular Failure in an Ovine Model.
    J Vis Exp. 2026;.
    PubMed    
    Abstract available
    
    

30. WHITE YN, Douglass M, Van Boerum J, Rebentisch A, et al
    Cardiac Catheterization for Assessment of Pulmonary Hypertension in Preterm Lambs.
    J Vis Exp. 2026;.
    PubMed    
    Abstract available
    
    

31. CUSTODIO JM, Rodgers N, Aggarwal V
    Digital Subtraction Pulmonary Angiography: A Useful Tool to Evaluate Pediatric Pulmonary Hypertension.
    Pediatr Cardiol. 2026 May 25. doi: 10.1007/s00246-026-04311.
    PubMed    
    Abstract available
    
    

32. YOO HHB, Rroku A, Thevathasan T
    Editorial: Pulmonary embolism and pulmonary hypertension: from acute management to long-term phenotyping.
    Front Cardiovasc Med. 2026;13:1851852.
    PubMed    
    
    
    

33. GILBOA-SAGY H, Romem A, Guber E, Epstein Shochet G, et al
    Transbronchial cryobiopsy is safe for patients with echocardiographic evidence of pulmonary hypertension: a blinded prospective cohort study.
    Front Med (Lausanne). 2026;13:1842852.
    PubMed    
    Abstract available
    
    

34. VANDERWILDE AJ, Miles KG, Becker KC, Critser PJ, et al
    Oxygen Consumption and Oxygen Pulse Patterns in Two Pediatric Patients With Pulmonary Hypertension and Different Clinical Responses: A Case Report.
    Case Rep Pediatr. 2026;2026:6697634.
    PubMed    
    Abstract available
    
    

35. PAVULURI SK, Zahn E, Sather J, Finocchio T, et al
    Eliminating a Latent Safety Threat in Emergency Care: A High-Reliability, Automated Strategy for Prostacyclin Continuity in Pulmonary Hypertension Patients.
    J Patient Saf. 2026 May 22. doi: 10.1097/PTS.0000000000001499.
    PubMed    
    
    
    

36. LANTOS L, Somogyvari Z, Szell A, Belteki G, et al
    [Use of inhaled nitric oxide during neonatal transport - a review of seven years of experience].
    Orv Hetil. 2026;167:824-832.
    PubMed    
    Abstract available
    
    

37. LI X, Li H, Feng B, Chen X, et al
    Expression of concern to "Post-treatment with Resolvin D1 attenuates pulmonary hypertension by inhibiting endothelial-to-mesenchymal transition" [Biomed. Pharmacother. 177 (2024) 117023].
    Biomed Pharmacother. 2026;199:119313.
    PubMed    
    
    
    

38. DIENER J, Soni H, Booe J, Darce J, et al
    Development of a long-acting relaxin for the treatment of pulmonary hypertension.
    Br J Pharmacol. 2026 May 22. doi: 10.1111/bph.70498.
    PubMed    
    Abstract available
    
    

39. LU H, Zhang M, Gong S, Liang N, et al
    The CCL2 network in pulmonary hypertension: Potential therapeutic targets.
    Cell Signal. 2026;145:112606.
    PubMed    
    Abstract available
    
    

40. ZHOU WY, Wu XL, Wang SY, Zhang XY, et al
    TBX5-GATA4 interaction aggravates pulmonary artery smooth muscle proliferation and pathogenesis of pulmonary arterial hypertension through transcriptional co-activating CDK18.
    Life Sci. 2026;398:124453.
    PubMed    
    Abstract available
    
    

41. ZHAO J, Shi G, Han H, Zeng M, et al
    Dual-Scale Liposomal Assembly Enables Alveolar Macrophage-Targeted Gene Delivery in High-Altitude Pulmonary Edema and Acute Lung Injury.
    ACS Nano. 2026;20:14458-14478.
    PubMed    
    Abstract available
    
    

42. LI M, Wang Y, Liang X, Zhao C, et al
    Identification of an Hsp110/HDAC6 Dual-Target Inhibitor for the Effective Treatment of Pulmonary Arterial Hypertension via Synergistic Blockade of Vascular Remodeling.
    J Med Chem. 2026;69:12205-12222.
    PubMed    
    Abstract available
    
    

43. LUO Q, Li S, Huang Z, Ran Y, et al
    Prognostic value of TAPSE/sPAP in pulmonary arterial hypertension: a systematic review and meta-analysis.
    Respir Med. 2026;258:108861.
    PubMed    
    Abstract available
    
    

44. SALIBE-FILHO W, Zorze Rossetto N, Tatagiba LS, de Deus MontAlverne Parente Y, et al
    Evaluating sotatercept in the treatment of pulmonary arterial hypertension.
    Future Cardiol. 2026;22:463-472.
    PubMed    
    Abstract available
    
    

45. HUANG S, Chen Z, Gong W, Song Y, et al
    Kisspeptin-10 attenuates pulmonary arterial hypertension via restoration of mitochondrial function in pulmonary artery smooth muscle cells.
    Neuropeptides. 2026;117:102611.
    PubMed    
    Abstract available
    
    

46. QIU L, Lu T, Zhang J, Liu M, et al
    Targeting REV-ERBalpha/BNIP3 axis attenuates pulmonary arterial hypertension by repressing mitophagy in mice.
    Nat Commun. 2026;17:4793.
    PubMed    
    Abstract available
    
    

47. HUANG W, Wang X, Wu W, Wang Y, et al
    SMAD7 Downregulation Promotes Ferroptosis in Pulmonary Arterial Hypertension Via the TGF-beta1-SMAD2/3 Pathway.
    Shock. 2026;65:1021-1036.
    PubMed    
    Abstract available
    
    

48. SI S, Wang H, Xu Y, Wang J, et al
    Scalable Production of Multi-Source Hybrid Biomimetic Exosomes Co-Loaded with Therapeutic Plasmids for Treatment of High-Altitude Pulmonary Edema.
    Adv Healthc Mater. 2026;15:e04014.
    PubMed    
    Abstract available
    
    

49. BERGER RMF, Dunbar Ivy D, Borissoff JI, Cerovic S, et al
    Macitentan in Pediatric Pulmonary Arterial Hypertension (TOMORROW): A Randomized Clinical Trial.
    J Pediatr. 2026;293:115057.
    PubMed    
    Abstract available
    
    

50. TAZIBT D, Vacelet V, Vendeville S, Seronde MF, et al
    Coexistence of hepatopulmonary syndrome and portopulmonary hypertension before a liver transplantation: a case report and review of the literature.
    Eur J Gastroenterol Hepatol. 2026;38:874-878.
    PubMed    
    Abstract available
    
    

51. WREN JT JR, Hyland RM, McNamara PJ
    Initial Hemodynamic Phenotypes and Clinical Trajectory in Congenital Diaphragmatic Hernia: A Pilot Study.
    J Pediatr. 2026 Feb 19:115044. doi: 10.1016/j.jpeds.2026.115044.
    PubMed    
    Abstract available
    
    

52. IWAHORI T, Hayashi Y, Tsuchiya H, Hirata T, et al
    Regional Disparities in Access to Specialized Facilities and Prescription Preference for Initial Pulmonary Arterial Hypertension Treatment?- A Nationwide Study Using the National Database of Health Insurance Claims.
    Circ J. 2026;90:736-738.
    PubMed    
    Abstract available
    
    

53. LIU HY, Cheng MC, Chien SJ, Lin YJ, et al
    The impact and outcome of the presence of ductus arteriosus in neonatal peripheral extracorporeal membrane oxygenation.
    Pediatr Neonatol. 2026;67:288-292.
    PubMed    
    Abstract available
    
    

54. NAKAMURA T, Tahara N, Koga Y, Yamagata Y, et al
    Right Ventricular Metabolic Adaptation to Afterload and Heterogeneous RV-Pulmonary Arterial Coupling in Pre-Capillary Pulmonary Hypertension: An FDG-PET/CMR Study.
    J Nucl Cardiol. 2026 Jun 3:102770. doi: 10.1016/j.nuclcard.2026.102770.
    PubMed    
    Abstract available
    
    

55. LI M, Zhang Y, Liu M, Lv C, et al
    A young woman with dramatic pulmonary hypertension and respiratory failure: a case report.
    Front Med (Lausanne). 2026;13:1788480.
    PubMed    
    Abstract available
    
    

56. 
    Erratum: Chinese Herbal Medicine in Hypoxic Pulmonary Hypertension Treatment: Mechanisms, Progress, and Future Directions [Corrigendum].
    Drug Des Devel Ther. 2026;20:570449.
    PubMed    
    Abstract available
    
    

57. BAJOUKA J, Matti C, Touza G, Patel K, et al
    Multifactorial Pulmonary Hypertension: Converging Roles of Sarcoidosis, Heart Failure With Reduced Ejection Fraction, and Chronic Thromboembolic Disease.
    Cureus. 2026;18:e108187.
    PubMed    
    Abstract available
    
    

58. XIANG XJ, Ma DY, Liu MY, Ma L, et al
    Association between a composite metabolic index and mortality in critically ill patients with pulmonary hypertension: a retrospective cohort study.
    Sci Rep. 2026 Jun 3. doi: 10.1038/s41598-026-56432.
    PubMed    
    Abstract available
    
    

59. JIANG WD, Xu MY, Chen ZY, Chen Q, et al
    Loss of Brg1 prevents the progression of pulmonary hypertension by inhibiting Nrf2 expression.
    Sci Rep. 2026 Jun 3. doi: 10.1038/s41598-026-55301.
    PubMed    
    Abstract available
    
    

60. XU XR, Chen L, Sun KY, Qin XB, et al
    Dissociation of UPR signaling and ER ultrastructure during 4-PBA therapy in shunt-driven pulmonary hypertension.
    Am J Hypertens. 2026 Jun 3:hpag052. doi: 10.1093.
    PubMed    
    Abstract available
    
    

61. SUN ZY, Zhao XX, Pan-Han, Li J, et al
    Assessment of Right Atrial Function in Patients With Chronic Thromboembolic Pulmonary Hypertension.
    Echocardiography. 2026;43:e70444.
    PubMed    
    Abstract available
    
    

62. BASKIN SM, Pulton DA, Vasant D, Salamanca-Padilla YY, et al
    Early predictors and outcomes of mechanical circulatory support use during single lung transplant for secondary pulmonary hypertension: A large single-center experience.
    JHLT Open. 2026;13:100587.
    PubMed    
    Abstract available
    
    

63. DONG Y, Lu C, Luo T, Zeng J, et al
    Isolated Absence of the Right Pulmonary Artery: A Rare Cause of Pulmonary Hypertension in Adults.
    Eur Heart J Cardiovasc Imaging. 2026 Jun 2:jeag136. doi: 10.1093.
    PubMed    
    
    
    

64. FAVRIN G, Cappello E, Rattotti S, Picone C, et al
    Regression of T-LGL leukemia in a patient treated with sildenafil for pulmonary hypertension.
    Leuk Res. 2026;167:108257.
    PubMed    
    
    
    

65. WANG X, Wang Y, Wang H, Zeng Z, et al
    Leveraging Untargeted Metabolomics and Molecular Dynamics Simulation Unraveling the Multi-Target Mechanism of Taohong Siwu Decoction against Pulmonary Hypertension.
    Curr Pharm Des. 2026 May 25. doi: 10.2174/0113816128446449260213204759.
    PubMed    
    Abstract available
    
    

66. CASTIGLIONE A, Bergstrom E, Kjellstrom B, Radegran G, et al
    CMR-derived left ventricular pressure-volume loops enhance individualized assessment of disease severity and prognosis in pulmonary arterial hypertension in adults.
    Physiol Rep. 2026;14:e70935.
    PubMed    
    Abstract available
    
    

67. ISHIMARU S, Mizuno S, Tanada T, Saito D, et al
    [Pulmonary Arterial Hypertension Impairs Duodenal Barrier Integrity in Rats].
    Yakugaku Zasshi. 2026;146:603-610.
    PubMed    
    Abstract available
    
    

68. VALENTIN S, Odille F, Sorel D, Baptista BR, et al
    Multimodal evaluation in pulmonary hypertension: Contextualizing native T1 mapping.
    Respir Med Res. 2026;89:101279.
    PubMed    
    
    
    

69. MATHAVAN A, Mathavan A, Krekora U, Rojas ORG, et al
    BMPR2 Splice-Site Variant in a Patient With Pulmonary Arteriovenous Malformation and Delayed-Onset Pulmonary Arterial Hypertension: A Case Report and Mechanistic Phenocopy Hypothesis.
    Am J Med Genet A. 2026;200:1682-1690.
    PubMed    
    Abstract available
    
    

70. UYGUR B, Memic Sancar K, Bulut U, Kahraman S, et al
    Role of the coronary sinus in risk stratification and prognostic evaluation of idiopathic pulmonary arterial hypertension.
    Herz. 2026;51:222-229.
    PubMed    
    Abstract available
    
    

71. FARINA JM, Scalia IG, Pietri MP, Abbas MT, et al
    Evaluation of ePLAR, the echocardiographic pulmonary to left atrial ratio, in a large cohort with pulmonary hypertension.
    Eur Heart J Open. 2025;6:oeaf174.
    PubMed    
    Abstract available
    
    

72. TAMILSELVAN K, Arumugam A, Vadivelu M, Senthilkumar K, et al
    Prevalence and Associated Echocardiographic Findings of Pulmonary Hypertension in Chronic Kidney Disease: A Cross-Sectional Study.
    Cureus. 2026;18:e108609.
    PubMed    
    Abstract available
    
    

73. LARPNARONGCHAI S, Maneenil G, Thatrimontrichai A, Dissaneevate S, et al
    Clinical Factors Associated with Ventilator-Free Days in Newborns with Persistent Pulmonary Hypertension of the Newborn: A Retrospective Cohort Study in Thailand.
    J Clin Med. 2026;15:4377.
    PubMed    
    Abstract available
    
    

74. ROSTAGNO C, Cartei A, Rubbieri G, Ceccofiglio A, et al
    Echocardiography Does Not Delay Surgery in Elderly Patients with Hip Fractures, and Pulmonary Hypertension and Decreased Left Ventricular Ejection Fraction Are Associated with In-Hospital Mortality.
    J Clin Med. 2026;15:4284.
    PubMed    
    Abstract available
    
    

75. CHEN X, Su J, Liu H, Qin Y, et al
    Endothelial-to-Mesenchymal Transition Mechanisms in Vascular Remodeling of Pulmonary Hypertension.
    Int J Mol Sci. 2026;27:4951.
    PubMed    
    Abstract available
    
    

76. MOOERS EA, Lakshminrusimha S, Konduri GG
    Advances in the Management of Persistent Pulmonary Hypertension of the Newborn.
    Clin Perinatol. 2026;53:297-316.
    PubMed    
    Abstract available
    
    

77. HINOJOSA W, Rodriguez-Munoz D, Lopez-Alacid I, Ynsaurriaga FA, et al
    Atrial flutter ablation in pulmonary hypertension: a national referral center experience.
    Rev Esp Cardiol (Engl Ed). 2026 Jun 11:S1885-5857(26)00127.
    PubMed    
    
    
    

78. ROBERTSON L, Bunclark K, Toshner M, Pepke-Zaba J, et al
    Diurnal and seasonal variation in six-minute walk distance in pulmonary hypertension: Implications for clinical monitoring.
    Chron Respir Dis. 2026;23:14799731261460039.
    PubMed    
    Abstract available
    
    

79. KISHIGAMI D, Shimokawahara H, Takahashi K, Kobashi S, et al
    Three-Color SUV(LV)-Normalized SPECT/CT to Visualize Dynamic Pulmonary Perfusion in Chronic Thromboembolic Pulmonary Hypertension.
    Circ Rep. 2026;8:1011-1012.
    PubMed    
    Abstract available
    
    

80. KASAHARA T, Yamashita J, Komatsu I, Shimahara Y, et al
    Combined therapeutic strategy of balloon pulmonary angioplasty before and after pulmonary endarterectomy in a patient with severe chronic thromboembolic pulmonary hypertension with Kartagener's syndrome: a case report.
    Eur Heart J Case Rep. 2025;10:ytaf349.
    PubMed    
    Abstract available
    
    

81. RYSZKIEWICZ P, Remiszewski P, Pedzinska-Betiuk A, Minczuk K, et al
    Chronic simultaneous inducible nitric oxide synthase (iNOS) and peripheral cannabinoid CB(1) receptors blockade ameliorates pulmonary hypertension in monocrotaline-induced rat model.
    Front Pharmacol. 2026;17:1831802.
    PubMed    
    Abstract available
    
    

82. LESCANO A, Pulido Zamudio T, Conde Camacho R, Caro FM, et al
    Latin American expert opinion paper on the diagnosis and treatment of pulmonary hypertension associated with interstitial lung disease.
    Front Med (Lausanne). 2026;13:1798347.
    PubMed    
    Abstract available
    
    

83. NASER JA, Ibrahim HH, Rahme S, Andi K, et al
    Prognostic Value of Tricuspid Regurgitation in Pulmonary Hypertension and Among the Different WHO Groups.
    JACC Cardiovasc Imaging. 2026 Jun 10:S1936-878X(26)00260.
    PubMed    
    Abstract available
    
    

84. BROSSAT C, Jambon-Barbara C, Hlavaty A, Chaumais MC, et al
    Fenfluramine-associated pulmonary hypertension: a study of adverse events reporting system FAERS.
    ERJ Open Res. 2026;12:01450-2025.
    PubMed    
    Abstract available
    
    

85. PLUNKETT MJ, Sayegh ALC, Lewis RA, McWilliams TJ, et al
    Slow deep breathing reduces muscle sympathetic nerve activity and improves breathing efficiency in pulmonary hypertension.
    ERJ Open Res. 2026;12:01329-2025.
    PubMed    
    Abstract available
    
    

86. ZHANG JJ, Huang YQ, Liu XK, Sun XL, et al
    Research advances in chronic thromboembolic pulmonary hypertension: from pathological mechanisms to multidisciplinary management.
    Front Cardiovasc Med. 2026;13:1832792.
    PubMed    
    Abstract available
    
    

87. CUSMAI C, Gulati S, Laskey D, Sun T, et al
    Successful Single Lung Transplantation in Severe Group III Pulmonary Hypertension.
    Ann Thorac Surg Short Rep. 2025;4:423-427.
    PubMed    
    Abstract available
    
    

88. AHANGAR H, Ghasemi Palangi M, Gohari S, Yasami P, et al
    A Case of Chronic Thromboembolic Pulmonary Hypertension and Pregnancy, Managed With Pulmonary Endarterectomy: Clinical Challenges, Case Report, and Literature Review.
    Clin Case Rep. 2026;14:e72864.
    PubMed    
    Abstract available
    
    

89. GONG D, Liu R, Deng X, Xing J, et al
    Licochalcone B alleviates pulmonary vascular remodeling via inhibiting Furin/TGF-beta1 in pulmonary hypertension.
    Phytomedicine. 2026;158:158373.
    PubMed    
    Abstract available
    
    

90. DING QS, Li M, Wang YH, Li L, et al
    Echocardiographic evaluation of right ventricular function before and after percutaneous coronary intervention in patients with coronary artery disease and pulmonary hypertension: A single-center retrospective cohort study.
    Medicine (Baltimore). 2026;105:e49028.
    PubMed    
    Abstract available
    
    

91. LI OM, Ghani H, Appenzeller P, Amaral-Almeida L, et al
    Comparing bridging drug therapy approaches prior to balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension: a prospective analysis from the national UK CURATE registry.
    Open Heart. 2026;13:e004169.
    PubMed    
    Abstract available
    
    

92. BAUER M, Santhanam L, Steppan J
    Pulsed Wave Doppler Assessment of Diastolic Dysfunction in the ZSF-1 Rat Model of Pulmonary Hypertension Due to Left Heart Disease.
    J Vis Exp. 2026;.
    PubMed    
    Abstract available
    
    

93. DEVALLA L, Wagh PB, Ghewade B
    A rare etiology of pulmonary hypertension: The scimitar syndrome.
    J Family Med Prim Care. 2026;15:1445-1447.
    PubMed    
    Abstract available
    
    

94. NILSSON CN, Aljohani OA, Smith MA, Durand R, et al
    Trametinib Therapy for Hypertrophic Cardiomyopathy and Pulmonary Hypertension in a Child With RAF1-Related Noonan Syndrome (p.Ser257Leu): A Case Report.
    Clin Case Rep. 2026;14:e72831.
    PubMed    
    Abstract available
    
    

95. ABDUL KHALEK J, Al Hajjar M, Al-Khalil Z, Salem J, et al
    Unveiling the Link Between COVID-19 and Pulmonary Hypertension.
    Can J Infect Dis Med Microbiol. 2026;2026:9352258.
    PubMed    
    Abstract available
    
    

96. FUJII H, Isobe S, Taniguchi Y, Tamura Y, et al
    Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension in an Adolescent With a Novel Frameshift Variant in PROS1.
    Pulm Circ. 2026;16:e70335.
    PubMed    
    Abstract available
    
    

97. POSEY JN, Jordan M, Olsen-Dufour A, Nguyen TN, et al
    Interferon receptor gene dosage differentially regulates hypoxia-induced platelet activation and pulmonary hypertension in down syndrome.
    Front Immunol. 2026;17:1832057.
    PubMed    
    Abstract available
    
    

98. KARIA N, Murphy D, Howard L, Johnson M, et al
    Significance of echocardiographic metrics including TRV and TAPSE/SPAP in mild haemodynamic pulmonary hypertension - data from EVIDENCE-PAH UK.
    Echo Res Pract. 2026;13:20.
    PubMed    
    Abstract available
    
    

99. DAOUD A, Goldin G, Goren L, Bagga A, et al
    Echocardiographic characterization of combined postcapillary and precapillary pulmonary hypertension in systemic sclerosis with preserved ejection fraction.
    Echo Res Pract. 2026;13:18.
    PubMed    
    Abstract available
    
    

100. WILD CJB, Coghlan G, Charalampopoulos A, Hameed A, et al
     The impact of right ventricular free wall strain on current international echocardiography guidelines for the assessment of pulmonary hypertension.
     Echo Res Pract. 2026;13:17.
     PubMed    
     Abstract available
     
     

101. HERMANSSON FN, Celestin BE, Bagherzadeh SP, Fahed G, et al
     Impact of guideline definitions on right ventricular diameter in echocardiography: an automated analysis in controls and patients with pulmonary hypertension.
     Echo Res Pract. 2026;13:21.
     PubMed    
     Abstract available
     
     

102. KOHLI A, Mokhlesi B
     Positive Airway Pressure Therapy for Pulmonary Hypertension Associated with Sleep-disordered Breathing.
     Arch Bronconeumol. 2026 May 11:S0300-2896(26)00171.
     PubMed    
     
     
     

103. AWAD A, Hamza M, Rayes A, Al Haly B, et al
     Impact of pulmonary hypertension on long-term clinical outcomes in patients undergoing percutaneous coronary intervention for acute coronary syndrome: Results from a large PCI registry.
     Heart Lung. 2026;79:102841.
     PubMed    
     Abstract available
     
     

104. KUMAR A, Mahajan A, Krishnamachary B, Chen L, et al
     Exposure Pattern Determines Methamphetamine-Induced Right Ventricular Dysfunction and Vascular Remodeling.
     Compr Physiol. 2026;16:e70191.
     PubMed    
     Abstract available
     
     

105. AKTAS I, Yasar E
     Neutrophil Percentage-to-Albumin Ratio as a Novel Biomarker in Patients with Group 1 Pulmonary Arterial Hypertension.
     Niger J Clin Pract. 2026;29:559-566.
     PubMed    
     Abstract available
     
     

106. LIU J, Guo Y, Huang J, Gao Z, et al
     Adipokine Nesfatin-1 Mediates Endothelial Dysfunction by Suppressing MEF2B/BMPR1A During Pulmonary Vascular Remodeling.
     J Am Heart Assoc. 2026;15:e047528.
     PubMed    
     Abstract available
     
     

107. WELLS M, Smith T, Domsic RT, Anilkumar A, et al
     The clinical utility of telangiectasia quantification as markers of vascular disease progression in systemic sclerosis.
     Rheumatology (Oxford). 2026;65:keag267.
     PubMed    
     Abstract available
     
     

108. CHEN S, Yin J, Kan Z, Li X, et al
     Angiopoietin-2-mediated integrin alpha5beta1 and FAK signaling contributes to pulmonary arterial hypertension pathogenesis.
     Life Sci. 2026;399:124441.
     PubMed    
     Abstract available
     
     

109. MA Q, You S
     Neutrophil extracellular traps-related biomarkers in idiopathic pulmonary arterial hypertension: A machine learning-based identification and experimental validation study.
     Mol Immunol. 2026;195:25-39.
     PubMed    
     Abstract available
     
     

110. MIRANDA-ALCARAZ L, Mora-Gomez M, Gallego-Zazo N, Cruz-Utrilla A, et al
     Expanding the genetic burden of low-evidence genes in pulmonary arterial hypertension.
     Eur J Hum Genet. 2026;34:831-839.
     PubMed    
     Abstract available
     
     

111. PORRES-AGUILAR M, Johns E, Piazza G, McBane R, et al
     Exercise for treatment and prevention of post-pulmonary embolism syndrome: A review.
     Vasc Med. 2026;31:409-420.
     PubMed    
     Abstract available
     
     

112. BOROVIKOVA I, Uporov I, Okhrimenko G, Zamyatin V, et al
     Molecular dynamics simulations refine the pathogenicity of ACVRL1 kinase domain variants by quantifying impacts on ATP binding in pulmonary arterial hypertension.
     J Struct Biol. 2026;218:108315.
     PubMed    
     Abstract available
     
     

113. MANZI G, Badagliacca R, D'Alto M, Ghio S, et al
     2025 expert consensus on the use of parenteral prostanoids in incident and prevalent PAH patients: The Italian perspective.
     Vascul Pharmacol. 2026;163:107590.
     PubMed    
     Abstract available
     
     

114. GHENGHEA R, Pyra P, Dulac Y, Guitarte A, et al
     Myocardial work during various right ventricle load conditions in a paediatric population.
     Arch Cardiovasc Dis. 2026;119.
     PubMed    
     Abstract available
     
     

115. GARCIA AR, Vollmer I, Blanco I, San Jose Estepar R, et al
     Characterization of CT-Derived Pulmonary Vascular Abnormalities Associated with Pulmonary Hypertension in Chronic Lung Disease.
     Chest. 2026 May 27:S0012-3692(26)00704-X. doi: 10.1016/j.chest.2026.
     PubMed    
     Abstract available
     
     

116. TOSHNER M, Morris N
     Actigraphy in Pulmonary Hypertension Clinical Trials: Time to Step Up?
     Chest. 2026;169:1444-1446.
     PubMed    
     
     
     

117. LYON ZM, Kolaitis NA
     Is It Time to Focus Efforts to Better Understand Group 3 Pulmonary Hypertension in Patients With Cystic Fibrosis and Non-Cystic Fibrosis Bronchiectasis?
     Chest. 2026;169:1432-1433.
     PubMed    
     
     
     

118. MOSS ME, Klouda T, Li Y, Liu Y, et al
     Hypoxia Induces Adaptive Lymphangiogenesis via Cd74 and Vegfr3 to Modulate Pulmonary Hypertension.
     Circ Res. 2026 Jun 3. doi: 10.1161/CIRCRESAHA.126.326822.
     PubMed    
     Abstract available
     
     

119. TORO V, Mougin M, Brossat C, Jambon-Barbara C, et al
     Correction to: Breast Cancer Reveals Latent BMPR2-Related Susceptibility to Pulmonary Hypertension.
     Circulation. 2026;153:e1362.
     PubMed    
     
     
     

120. HOU Y, Li Q, Wei TW, Lin X, et al
     Hypoxia Upregulation of BACH1 Aggravates Pulmonary Hypertension Through TGFBR2/SMAD Pathways.
     Circulation. 2026 May 26. doi: 10.1161/CIRCULATIONAHA.124.073606.
     PubMed    
     Abstract available
     
     

121. WANG Q, Tian J, Liu D, Zheng T, et al
     Endothelial SHMT2 Drives Pulmonary Vascular Remodeling Through Noncanonical Pathway in Pulmonary Hypertension.
     Circulation. 2026 Jun 10. doi: 10.1161/CIRCULATIONAHA.125.066183.
     PubMed    
     Abstract available
     
     

122. GUY K, Isaiah A
     Association between upper airway obstruction and pulmonary hypertension in children with Down syndrome.
     Curr Opin Pulm Med. 2026 May 26. doi: 10.1097/MCP.0000000000001287.
     PubMed    
     Abstract available
     
     

123. LEUZZI FR, Clausen ES, Dilling DF
     The changing face of lung transplant candidates.
     Curr Opin Pulm Med. 2026;32:335-340.
     PubMed    
     Abstract available
     
     

124. BIRNHUBER A, Zeder K, Kwapiszewska G
     Preclinical and clinical advances in pulmonary hypertension associated with systemic sclerosis.
     Curr Opin Pulm Med. 2026 Jun 11. doi: 10.1097/MCP.0000000000001284.
     PubMed    
     Abstract available
     
     

125. SHAMS SM, Maldarelli ME, Yin Y, Cassady S, et al
     A clinical support tool using artificial intelligence to diagnose pulmonary hypertension.
     Eur Respir J. 2026 Jun 4:2600125. doi: 10.1183/13993003.00125-2026.
     PubMed    
     
     
     

126. APPENZELLER P, Toshner M
     Do risk scores in chronic thromboembolic pulmonary hypertension need to account for inflammation?
     Eur Respir J. 2026;67:2600283.
     PubMed    
     
     
     

127. GARRY JD, Ivy DD, Austin ED
     From case reports to a cohort: illuminating the spectrum of pulmonary hypertension in Noonan syndrome.
     Eur Respir J. 2026;67:2600064.
     PubMed    
     
     
     

128. KIM NH, Perez VJ, Kingrey J, David Hardy W, et al
     Methamphetamine-associated PAH on the rise in the US: geographic trends & disparities in patient demographics and treatment strategies.
     J Heart Lung Transplant. 2026;45:1123-1132.
     PubMed    
     Abstract available
     
     

129. GEUBE M, Abraham A, Kelava M, Bustamante SE, et al
     Cardiopulmonary Effects of Vasopressin Versus Norepinephrine in Cardiac Surgery Patients: a Single Cluster-Randomized Cross-over Trial.
     J Thorac Cardiovasc Surg. 2025 Nov 19:S0022-5223(25)00978.
     PubMed    
     Abstract available
     
     

130. YUAN Z, Chen J, Chen D, Xu G, et al
     Correction: Megakaryocytic Leukemia 1 (MKL1) Regulates Hypoxia Induced Pulmonary Hypertension in Rats.
     PLoS One. 2026;21:e0350157.
     PubMed    
     Abstract available
     
     

131. YANG X, Zhou B, Yang Y, Dong Y, et al
     Integrative transcriptomic analysis identifies immune-associated candidate genes and altered immune cell infiltration in pulmonary arterial hypertension.
     PLoS One. 2026;21:e0350015.
     PubMed    
     Abstract available
     
     

132. PAN Q, Chen H, Pan H, Hu Z, et al
     Exploratory research on drugs after lung surgery based on real-world data from the FDA adverse event reporting system database.
     PLoS One. 2026;21:e0346792.
     PubMed    
     Abstract available
     
     

133. HOSOKAWA K, Yamasaki Y, Kishimoto J, Nagayama T, et al
     Facilitating early diagnosis of chronic thromboembolic pulmonary hypertension with dynamic chest radiography: Protocol for a multicenter, assessor-blinded, case-wise randomized superiority reader study (FIND-DCR).
     PLoS One. 2026;21:e0350858.
     PubMed    
     Abstract available